Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bristol-Myers Squibb

This article was originally published in The Tan Sheet

Executive Summary

Will distribute Excedrin samples at post offices in 11 U.S. cities on April 15 to last-minute tax filers as part of the company's "Excedrin Headache #1040" promotion. Kicked off in mid- March with radio promotions in 17 cities advertising a toll-free number for consumers to call for tax advice, the promo will award "tax relief kits" featuring samples and other Excedrin paraphernalia to those callers who present the "most headache causing questions." BMS also will place radio remotes in high- traffic areas in 17 cities through April 15 to give away samples, cash and prizes. In-store sampling and sweepstakes at grocery stores also will commence in April. Handled by Mona Meyer McGrath & Gavin of Minneapolis, the promo included a national free- standing insert released at the end of March with 50" coupons for Excedrin, Excedrin IB, Aspirin Free Excedrin, and Aspirin Free Excedrin PM.

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts